Could rosemary help tame diabetes inflammation?

NCT ID NCT07541729

Ongoing Disease control Sponsor: Universidad Autonoma de Zacatecas Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early-stage trial is testing whether a rosemary extract supplement can improve markers of oxidative stress and inflammation in people with type 2 diabetes. Forty adults with stable diabetes will take either the extract or a placebo for 12 weeks. The study focuses on blood biomarkers, not direct health outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: rosemary extract
What this could lead to: If it works, this could point toward a natural supplement to help manage oxidative stress and inflammation in type 2 diabetes.
What could go wrong: This is a very early phase 1 trial with only 40 people, so results may not be conclusive. It's testing biomarkers, not clinical outcomes, so even positive results may not translate to real-world benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFLAMMATION CHRONIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Inflammation type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INFLAMMATION CHRONIC OXIDATIVE STRESS TYPE 2 DIABETES MELLITUS (T2DM)

Contacts and locations

Locations

ISSSTE (Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado)

Zacatecas City, Zacatecas, 98160, Mexico

More trials for these conditions

Other studies related to the condition(s) this trial covers.